GnRH Associated Peptide (GAP) (1-13), human (Synonyms:L-alpha-天冬氨酰-L-丙氨酰-L-alpha-谷氨酰-L-天冬氨酰胺酰-L-亮氨酰-L-异亮氨酰-L-alpha-天冬氨酰-L-丝氨酰-L-苯丙氨酰-L-谷氨酰胺酰-L-alpha-谷氨酰-L-异亮氨酰-L-缬氨酸)
目录号 : KG12123 CAS No. : 100111-07-7 纯度 : 98%
Sequence: Asp-Ala-Glu-Asn-Leu-Ile-Asp-Ser-Phe-Gln-Glu-Ile-Val The cloned complementary DNA sequence encoding the human gonadotropin-releasing hormone (GnRH) precursor protein was used to construct an expression vector for the bacterial synthesis of the 56-amino acid GnRH-associated peptide (GAP). GAP was found to be a potent inhibitor of prolactin secretion and to stimulate the release of gonadotropins. Active immunization with peptides corresponding to GAP sequences led to greatly increased prolactin secretion. Gonadotropin-releasing hormone (GnRH) is known and named for its essential role in vertebrate reproduction. Release of this decapeptide from neurons in the hypothalamus controls pituitary gonadotropin levels that, in turn, regulate the gonadal state. The importance of GnRH is underscored by its widespread expression and conservation across vertebrate taxa. Also, GnRH-associated peptide (GAP) is co-secreted with GnRH into the hypophyseal portal bloodstream.
规格 价格 是否有货 数量
1mg
In-stock
立即试用
5mg
In-stock
10mg
In-stock
25mg
In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
分子式
C65H101N15O25
分子量
1492.58
CAS号
100111-07-7
中文名称
L-alpha-天冬氨酰-L-丙氨酰-L-alpha-谷氨酰-L-天冬氨酰胺酰-L-亮氨酰-L-异亮氨酰-L-alpha-天冬氨酰-L-丝氨酰-L-苯丙氨酰-L-谷氨酰胺酰-L-alpha-谷氨酰-L-异亮氨酰-L-缬氨酸
储存方式
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
暂无相关参考文献
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
动物实验计算换算器
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。

配置后的溶液总体积:

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。